Cardiovascular Diseases Clinical Trial
— PaprikaOfficial title:
Patient Empowerment for Major Surgery Preparation @ Home: Multimodal Prehabilitation in Major Elective Surgery
Non-randomized monocentric open cohort study vs historical comparative group testing the efficacy of a multimodal prehabilitation program (based on physical activity, nutritional support and mental preparation) for unfit patients based on nutrition, physical activity and mental preparation in reducing postoperative complications in elective major surgery
Status | Recruiting |
Enrollment | 225 |
Est. completion date | December 31, 2021 |
Est. primary completion date | September 30, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 99 Years |
Eligibility | Inclusion Criteria: - Patient eligible to elective major surgery (digestive, orthopedic, vascular-thoracic, urologic) - Age > 70 years and/or American Society of Anesthesiologists (ASA) score 3-4 - or Unfit patient according to appropriate scores (Two among 3 scores (HAD, Physical activity score, nutritional score) below threshold). Unfit patients will be defined by at least 2 criteria if 'YES' answers: Physical activity: Less than 50% of WHO recommendations = less than 5000 steps/day or less than 75 min moderate activity/week or less than 12 min moderate activity/day Yes/No Malnutrition: BMI < 20 kg/m2 if < 70 years (or <22 if >70y) = undernutrition Yes/No or BMI>25 kg/m2 (= overweight to obesity) or Loss of appetite? Mental evaluation HAD (Hospital Anxiety and Depression) >8 for A or D score Yes/No - Diagnosis: Elective major surgery (digestive, orthopedic, vascular-thoracic, urologic) - Regulatory aspects: Be legally able to give consent Patient affiliated to social security Exclusion Criteria: - Planned surgery (less than 4 weeks at inclusion) - Urgent surgery - Patient with, at baseline, good to excellent physical, nutritional, mental status as defined by appropriate scores. - Patient considered not eligible to this program for physical or psychological reasons by the surgeon or the anesthetist - Persons referred in Articles L1121-5 to L1121-8 of the French code of public health (this corresponds to all persons protected: pregnant or parturient women, breastfeeding mothers, persons deprived of liberty by judicial or administrative decision, persons subject to a legal protection measure). |
Country | Name | City | State |
---|---|---|---|
France | Centre Hospitalier Universitaire Grenoble Alpes | La Tronche |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Grenoble | EIT Health, Hospital Clinic of Barcelona, Universitätsklinikum Köln, University Clinical Centre, Gdansk |
France,
Barberan-Garcia A, Ubre M, Pascual-Argente N, Risco R, Faner J, Balust J, Lacy AM, Puig-Junoy J, Roca J, Martinez-Palli G. Post-discharge impact and cost-consequence analysis of prehabilitation in high-risk patients undergoing major abdominal surgery: sec — View Citation
Barberan-Garcia A, Ubré M, Roca J, Lacy AM, Burgos F, Risco R, Momblán D, Balust J, Blanco I, Martínez-Pallí G. Personalised Prehabilitation in High-risk Patients Undergoing Elective Major Abdominal Surgery: A Randomized Blinded Controlled Trial. Ann Surg — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Rate of postoperative complications at Day-30 | Rate of postoperative complications at Day-30 classified following the standards of the European Society of Anaesthesiology and European Society of intensive Care Medicine. | at Day-30 post surgery | |
Secondary | Number and severity of postoperative complications | Number and severity of postoperative complications using Dindo-Clavien classification within 30 days | within 30 days post surgery | |
Secondary | Length of stay (ICU and Hospital) | Length of ICU stay and Length of hospital stay | within 30 days post surgery | |
Secondary | Hospital readmission | Hospital readmission within 30 days | within 30 days post surgery | |
Secondary | Direct cost | Valuation in euros of the direct cost from a 1-month hospital point of view (duration and type of stay, acts, GHM...) by integrating for the intervention group the cost of the pre-habilitation program. Care consumption at 6 months from a social security perspective (Probabilistic Matching National Health Data System)--> comparison of direct costs for the Prehab sessions (professional caregivers and materials costs) versus complication costs of control group | interventional group: 1 month-cost before surgery+1 month-post surgery / Control group: 1 month-cost post-surgery | |
Secondary | Physical activity health status | Health status based on physical activity score:GPAQ and DASI scores | a baseline, presurgery and 6 months post surgery | |
Secondary | Nutritional health status | Nutritional health status based on weight, appetite and ingesta measurements | at baseline, 1 month and 6 months | |
Secondary | Psychological health status | Psychological health status based on HAD, Perceived Stress Scale scores | at baseline, 1 month and 6 months | |
Secondary | Number of patient participation to program in relation to the number of eligible patients | Number of patient participation to program in relation to the number of eligible patients to assess faisability | During Paprika inclusion period | |
Secondary | Ratio patient participation to each session | Ratio patient participation to each session to assess faisability and limitation to participation | During Paprika 1 month-sessions | |
Secondary | Comparison with other centers | Comparison will be done with other cohorts using Paprika program (Barcelona, Gdansk and Köln) on common outcomes | through study completion, an average of 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|